Unknown

Dataset Information

0

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.


ABSTRACT: DNA vaccine-induced immunity can be enhanced by the co-delivery of synthetic gene-encoding molecular adjuvants. Many of these adjuvants have included cytokines, chemokines or co-stimulatory molecules that have been demonstrated to enhance vaccine-induced immunity by increasing the magnitude or type of immune responses and/or protective efficacy. In this way, through the use of adjuvants, immune responses can be highly customizable and functionally tailored for optimal efficacy against pathogen specific (i.e., infectious agent) or non-pathogen (i.e., cancer) antigens. In the novel study presented here, we examined the use of cellular transcription factors as molecular adjuvants. Specifically the co-delivery of (a) RelA, a subunit of the NF-?B transcription complex or (b) T-bet, a Th1-specific T box transcription factor, along with a prototypical DNA vaccine expressing HIV-1 proteins was evaluated. As well, all of the vaccines and adjuvants were administered to mice using in vivo electroporation (EP), a technology demonstrated to dramatically increase plasmid DNA transfection and subsequent transgene expression with concomitant enhancement of vaccine induced immune responses. As such, this study demonstrated that co-delivery of either adjuvant resulted in enhanced T and B cell responses, specifically characterized by increased T cell numbers, IFN-? production, as well as enhanced antibody responses. This study demonstrates the use of cellular transcription factors as adjuvants for enhancing DNA vaccine-induced immunity.

SUBMITTER: Shedlock DJ 

PROVIDER: S-EPMC4494262 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.

Shedlock Devon J DJ   Tingey Colleen C   Mahadevan Lavanya L   Hutnick Natalie N   Reuschel Emma L EL   Kudchodkar Sagar S   Flingai Seleeke S   Yan Jenny J   Kim Joseph J JJ   Ugen Kenneth E KE   Weiner David B DB   Muthumani Kar K  

Vaccines 20140325 2


DNA vaccine-induced immunity can be enhanced by the co-delivery of synthetic gene-encoding molecular adjuvants. Many of these adjuvants have included cytokines, chemokines or co-stimulatory molecules that have been demonstrated to enhance vaccine-induced immunity by increasing the magnitude or type of immune responses and/or protective efficacy. In this way, through the use of adjuvants, immune responses can be highly customizable and functionally tailored for optimal efficacy against pathogen s  ...[more]

Similar Datasets

| S-EPMC2829238 | biostudies-literature
| S-EPMC2862109 | biostudies-literature
| S-EPMC4633404 | biostudies-literature
| S-EPMC3067974 | biostudies-literature
| S-EPMC2682036 | biostudies-literature
| S-EPMC3462179 | biostudies-literature
| S-EPMC9644397 | biostudies-literature
| S-EPMC3689248 | biostudies-literature
| S-EPMC4330387 | biostudies-literature
| S-EPMC3302405 | biostudies-literature